Blood Screening Market Size, Share & Trends Report

Blood Screening Market Size, Share & Trends Analysis Report By Product (Reagent, Instrument), By Technology (NAT, ELISA, CLIA & EIA, NGS, Western Blotting), By Region, And Segment Forecasts, 2020 - 2024

Report ID: GVR-1-68038-215-0
Number of Pages: 90
Format: Electronic (PDF)

Historical Range: 2013 - 2018
Industry:Healthcare

Market segmentation

Blood Screening Technology Outlook (Revenue, USD Million, 2013 - 2024)
- Nucleic Acid Amplification Test (NAT)
- ELISA
- Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
- Next-Generation Sequencing (NGS)
- Western Blotting
Blood Screening Product Outlook (Revenue, USD Million, 2013 - 2024)
- Reagent
- Instrument
Blood ScreeningRegional Outlook (Revenue, USD Million, 2013 - 2024)
- North America
  - U.S.
    - U.S. Technology Outlook (Revenue, USD Million, 2013 - 2024)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next-Generation Sequencing (NGS)
      - Western Blotting
    - U.S. Product Outlook (Revenue, USD Million, 2013 - 2024)
      - Reagent
      - Instrument
  - Canada
    - Canada Technology Outlook (Revenue, USD Million, 2013 - 2024)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next-Generation Sequencing (NGS)
      - Western Blotting
    - Canada Product Outlook (Revenue, USD Million, 2013 - 2024)
      - Reagent
      - Instrument
- Europe
  - UK
    - UK Technology Outlook (Revenue, USD Million, 2013 - 2024)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next-Generation Sequencing (NGS)
      - Western Blotting
    - UK Product Outlook (Revenue, USD Million, 2013 - 2024)
      - Reagent
      - Instrument
  - Germany
    - Germany Technology Outlook (Revenue, USD Million, 2013 - 2024)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next-Generation Sequencing (NGS)
      - Western Blotting
    - Germany Product Outlook (Revenue, USD Million, 2013– 2024)
      - Reagent
      - Instrument
- Asia Pacific
  - Japan
    - Japan Technology Outlook (Revenue, USD Million, 2013 - 2024)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next-Generation Sequencing (NGS)
      - Western Blotting
    - Japan Product Outlook (Revenue, USD Million, 2013 - 2024)
      - Reagent
      - Instrument
  - China
    - China Technology Outlook (Revenue, USD Million, 2013 - 2024)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next-Generation Sequencing (NGS)
      - Western Blotting
    - China Product Outlook (Revenue, USD Million, 2013 - 2024)
      - Reagent
      - Instrument
  - India
    - India Technology Outlook (Revenue, USD Million, 2013 - 2024)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next-Generation Sequencing (NGS)
      - Western Blotting
    - India Product Outlook (Revenue, USD Million, 2013 - 2024)
      - Reagent
      - Instrument
- Latin America
  - Brazil
    - Brazil Technology Outlook (Revenue, USD Million, 2013 - 2024)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next-Generation Sequencing (NGS)
      - Western Blotting
    - Brazil Product Outlook (Revenue, USD Million, 2013 - 2024)
      - Reagent
      - Instrument
  - Mexico
    - Mexico Technology Outlook (Revenue, USD Million, 2013 - 2024)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next-Generation Sequencing (NGS)
      - Western Blotting
    - Mexico Product Outlook (Revenue, USD Million, 2013 - 2024)
      - Reagent
      - Instrument
- MEA
  - South Africa
    - South Africa Technology Outlook (Revenue, USD Million, 2013 - 2024)
      - Nucleic Acid Amplification Test (NAT)
      - ELISA
      - Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
      - Next-Generation Sequencing (NGS)
      - Western Blotting
    - South Africa Product Outlook (Revenue, USD Million, 2013 - 2024)
      - Reagent
      - Instrument

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2013 to 2024
Market estimates and forecast for product segments up to 2024
Regional market size and forecast for product segments up to 2024
Market estimates and forecast for application segments up to 2024
Regional market size and forecast for application segments up to 2024
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.